JP2014526890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014526890A5 JP2014526890A5 JP2014526189A JP2014526189A JP2014526890A5 JP 2014526890 A5 JP2014526890 A5 JP 2014526890A5 JP 2014526189 A JP2014526189 A JP 2014526189A JP 2014526189 A JP2014526189 A JP 2014526189A JP 2014526890 A5 JP2014526890 A5 JP 2014526890A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant protein
- tumstatin
- nucleic acid
- transferrin
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 15
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 15
- 102100033780 Collagen alpha-3(IV) chain Human genes 0.000 claims 12
- 102000004338 Transferrin Human genes 0.000 claims 12
- 108090000901 Transferrin Proteins 0.000 claims 12
- 239000012581 transferrin Substances 0.000 claims 12
- 108010012374 type IV collagen alpha3 chain Proteins 0.000 claims 12
- 150000007523 nucleic acids Chemical group 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 208000005590 Choroidal Neovascularization Diseases 0.000 claims 3
- 206010060823 Choroidal neovascularisation Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 239000013612 plasmid Substances 0.000 claims 2
- 201000002563 Histoplasmosis Diseases 0.000 claims 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000004177 elastic tissue Anatomy 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161524508P | 2011-08-17 | 2011-08-17 | |
| US61/524,508 | 2011-08-17 | ||
| PCT/US2012/051013 WO2013025846A2 (en) | 2011-08-17 | 2012-08-15 | Transferrin-tumstatin fusion protein and methods for producing and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014526890A JP2014526890A (ja) | 2014-10-09 |
| JP2014526890A5 true JP2014526890A5 (enExample) | 2015-08-27 |
| JP6073888B2 JP6073888B2 (ja) | 2017-02-01 |
Family
ID=47715692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014526189A Active JP6073888B2 (ja) | 2011-08-17 | 2012-08-15 | トランスフェリン−タムスタチン融合タンパク質並びにそれを作製する方法及びそれを使用する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9290562B2 (enExample) |
| EP (1) | EP2744831B1 (enExample) |
| JP (1) | JP6073888B2 (enExample) |
| CN (2) | CN110105453A (enExample) |
| AU (1) | AU2012296588B2 (enExample) |
| BR (1) | BR112014008680A2 (enExample) |
| CA (1) | CA2849015C (enExample) |
| DK (1) | DK2744831T3 (enExample) |
| ES (1) | ES2659161T3 (enExample) |
| NO (1) | NO2820418T3 (enExample) |
| PL (1) | PL2744831T3 (enExample) |
| PT (1) | PT2744831T (enExample) |
| SI (1) | SI2744831T1 (enExample) |
| TR (1) | TR201802686T4 (enExample) |
| WO (1) | WO2013025846A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995626B1 (en) * | 2013-05-06 | 2018-07-11 | China Pharmaceutical University | Bifunctional fusion proteins to inhibit angiogenesis in tumour microenvironment and to activate adaptive immune responses and the genes and uses thereof |
| EP3010525A1 (en) * | 2013-06-20 | 2016-04-27 | Novartis AG | Use of a vegf antagonist in treating choroidal neovascularisation |
| US11058750B2 (en) * | 2015-12-03 | 2021-07-13 | Mor Research Applications Ltd. | Compositions and methods for treatment of ocular diseases |
| KR101818151B1 (ko) | 2016-03-25 | 2018-01-16 | 한국과학기술원 | 트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물 |
| CN109053899B (zh) * | 2017-12-22 | 2021-11-16 | 湖南远泰生物技术有限公司 | 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672683A (en) | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| US20050192242A1 (en) | 1995-10-11 | 2005-09-01 | Neal Zane C. | Therapeutic fusion protein transgenes |
| KR100682666B1 (ko) * | 1998-06-17 | 2007-02-15 | 베쓰 이스라엘 디코니스 메디칼 센터 인크 | 항혈관형성 단백질 및 이들을 사용하는 방법 |
| EP1244701A1 (en) | 1999-12-23 | 2002-10-02 | Human Genome Sciences, Inc. | Transferrin polynucleotides, polypeptides, and antibodies |
| JP2005508623A (ja) | 2001-08-30 | 2005-04-07 | バイオレクシス ファーマシューティカル コーポレイション | 改変されたトランスフェリン融合タンパク質 |
| US8129504B2 (en) * | 2001-08-30 | 2012-03-06 | Biorexis Technology, Inc. | Oral delivery of modified transferrin fusion proteins |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| WO2003066824A2 (en) * | 2002-02-07 | 2003-08-14 | Aventis Behring Gmbh | Albumin-fused kunitz domain peptides |
| EP1670428A4 (en) | 2003-10-10 | 2008-03-12 | Univ Southern California | HYBRID PROTEINS G-CSF-TRANSFERRIN |
| US20050266067A1 (en) * | 2004-03-02 | 2005-12-01 | Shiladitya Sengupta | Nanocell drug delivery system |
| EP1812030A4 (en) * | 2004-10-14 | 2009-01-14 | Sopherion Therapeutics Inc | ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF |
| WO2006049983A2 (en) | 2004-10-27 | 2006-05-11 | Biorexis Pharmaceutical Corporation | Peptide yy modified transferrin fusion proteins |
| CA2606989A1 (en) * | 2005-04-29 | 2006-11-09 | Research Development Foundation | Vascular targeting of ocular neovascularization |
| AU2007211846B2 (en) | 2006-02-03 | 2013-05-23 | The University Of Sydney | A method of modulating cellular activity and agents for use therein |
| CN101070349B (zh) * | 2007-05-22 | 2010-10-13 | 山西康宝生物制品股份有限公司 | 具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用 |
| CN101092452A (zh) * | 2007-05-23 | 2007-12-26 | 哈尔滨医科大学 | 肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法 |
| WO2009086132A2 (en) * | 2007-12-20 | 2009-07-09 | University Of Southern California | Design of spacers to increase the expression of recombinant fusion proteins |
| AU2012222833B2 (en) | 2011-03-03 | 2017-03-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design and constructs |
-
2012
- 2012-08-15 DK DK12824616.2T patent/DK2744831T3/en active
- 2012-08-15 EP EP12824616.2A patent/EP2744831B1/en active Active
- 2012-08-15 CA CA2849015A patent/CA2849015C/en active Active
- 2012-08-15 PT PT128246162T patent/PT2744831T/pt unknown
- 2012-08-15 ES ES12824616.2T patent/ES2659161T3/es active Active
- 2012-08-15 SI SI201231232T patent/SI2744831T1/en unknown
- 2012-08-15 US US14/239,176 patent/US9290562B2/en active Active
- 2012-08-15 AU AU2012296588A patent/AU2012296588B2/en active Active
- 2012-08-15 WO PCT/US2012/051013 patent/WO2013025846A2/en not_active Ceased
- 2012-08-15 PL PL12824616T patent/PL2744831T3/pl unknown
- 2012-08-15 BR BR112014008680A patent/BR112014008680A2/pt unknown
- 2012-08-15 CN CN201910156923.9A patent/CN110105453A/zh active Pending
- 2012-08-15 JP JP2014526189A patent/JP6073888B2/ja active Active
- 2012-08-15 CN CN201280051256.4A patent/CN103998470A/zh active Pending
- 2012-08-15 TR TR2018/02686T patent/TR201802686T4/tr unknown
-
2013
- 2013-07-22 NO NO13745268A patent/NO2820418T3/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7012376B2 (ja) | 二重グリカン結合性ａａｖベクターのための方法および組成物 | |
| CN109715211B (zh) | 包含治疗性多肽的外来体 | |
| JP2017538401A5 (enExample) | ||
| JP2022188202A (ja) | 細胞並びにその使用方法及び製造方法 | |
| JP2014526890A5 (enExample) | ||
| JP2014520072A5 (enExample) | ||
| JP2021526817A (ja) | 親和性精製用の細胞外小胞操作 | |
| WO2015018331A1 (zh) | 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用 | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| IL292650A (en) | Chimeric antigen receptor T cells target il13ra2 | |
| JP2019500894A5 (enExample) | ||
| WO2021188996A1 (en) | Compositions and methods for enhanced lentiviral production | |
| JP2012115277A5 (enExample) | ||
| HRP20221447T1 (hr) | Fuzijski proteini koji sadrže dijelove za vezanje pdgf i vegf i postupci njihove upotrebe | |
| HRP20190472T4 (hr) | Klaudin-6 specifični imunoreceptori i t-stanični epitopi | |
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| JP2008056679A5 (enExample) | ||
| WO2013120012A3 (en) | Cdim binding proteins and uses thereof | |
| JP2014519830A5 (enExample) | ||
| CA3179420A1 (en) | Coronavirus antigen compositions and their uses | |
| JP2016519063A5 (enExample) | ||
| JP2022539377A (ja) | カチオン性脂質及びその使用 | |
| US20250064976A1 (en) | Engineered pnma proteins and delivery systems thereof | |
| JP2021521884A (ja) | ゲノム編集方法及び組成物 | |
| JP2016537995A5 (enExample) |